Robert K. Citrone is a well-known figure in the financial world. Rob, as many call him, is the co-founder of Discovery Capital Management, a hedge fund that has put the investor on the billionaires’ list. Others may remember him as one of the famous Tiger Cubs—former members of Julian Robertson’s Tiger Management who went on to establish their own successful hedge funds. Citrone also previously worked with George Soros, Fidelity Investments, and First Boston, where he focused on emerging markets. That focus hasn’t wavered since then.

Citrone’s voice matters a lot in the investment world. This has a lot to do with this hedge fund’s performance since its inception. In the last four quarters alone (up to Q4, 2024), for instance, the hedge fund has returned 48.03%. Citrone’s fund also managed to almost double its assets under management (AUM) in just one quarter; AUM grew from $0.8 billion in Q3 2024 to $1.5 billion in Q4 2024. The jump reflects a good year in the market, but that is just one way of looking at it. It is also evidence of renewed investor confidence in Citrone’s fund after a couple of ups and downs. For instance, the fund experienced negative returns in 2014 and 2015 and managed to reverse the trend in 2016.

READ ALSO: Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500 and 10 Value Stocks in Ken Fisher’s Portfolio.

No wonder when Rob speaks, investors listen. And many have been following his comments on the prevailing market conditions, especially after Trump threw global trade in a spin with a salvo of tariffs. Speaking to the Wall Street Journal earlier this month, Citrone regretted not selling more stocks before Trump took on the globe in a trade war. “I should have sold more,” he said.

This comment is rich coming from an investor who has been bearish most of this year. The Tiger Cub trimmed by half his net equity exposure to the United States at the end of January this year. His goal then was to “get flat to short in the coming weeks primarily in developed markets.” The main reason for the bearish stance was an anticipation of volatility once Trump took office.

And it now looks like the billionaire is looking South. Recent reports indicate that Citrone is betting on Argentina. While on a trip to the country, Citrone said that the next ten years “will be the decade of Latin America and Argentina will lead that process. Milei is a very important example for Latin America, but more than that, he is important for the world and for the United States. That’s why we must do everything possible to help Argentina.” But that doesn’t mean he has given up on US equities. Citrone expects a shallower recession than previously thought and he believes that there will be “strong growth in the second half of the year.”

Our Methodology

This list was compiled by analyzing Discovery Capital Management’s Q4 2024 SEC 13F filings. From the 78 holdings, we ranked the stocks based on the value of the billionaire’s stake in them. We then picked the top 10 stocks with the highest stake value. We also considered institutional interest in the stocks as of Q4 2024.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Billionaire Rob Citrone’s Top 10 Stock Picks

10. Genius Sports Limited (NYSE:GENI)

Rob Citrone’s Latest Stake Value: $45,374,483

Number of Hedge Funds Holding Stakes: 32

Genius Sports Limited (NYSE:GENI) is a sports data and technology company headquartered in London, the United Kingdom. It provides real-time sports data, analytics, and video streaming. It works with betting companies, gaming brands, broadcasters, and sports leagues.

The latest financial data shows that Genius Sports Limited’s (NYSE:GENI) finances are robust. The full-year 2024 revenue was $511 million, up 24% year-over-year, and net losses reduced by 26%. The company’s focus on operational efficiency has paid dividends, with Adjusted EBITDA soaring 61% to $86 million for the full year, expanding margins to 16.8%. The management projects continued momentum this year, with revenue expected to reach $620 million (21% growth).

Genius Sports Limited (NYSE:GENI) distinguishes itself through initiatives like its award-winning collaboration with EchoPoint Media for the Indianapolis 500, which improved ticket sales efficiency by 45%. The company is also expanding its technological reach, launching data-driven broadcasts for NBA 2K25 and Madden NFL Cast, and introducing advanced player tracking for France’s Ligue de Football Professionnel. Analysts maintain a Strong Buy consensus on the company’s shares with a median 12-month price target suggesting a 17.60% upside potential from current levels as of April 17.

9. The Boeing Company (NYSE:BA)

Rob Citrone’s Latest Stake Value: $45,860,700

Number of Hedge Funds Holding Stakes: 96

The Boeing Company (NYSE:BA) is a global aerospace company that designs, builds, and sells airplanes, helicopters, satellites, and defense systems. Some of its popular products include commercial aircraft like the 737, 777, and 787. The company serves airlines, governments, space agencies, and defense organizations worldwide.

This year is already promising for Boeing (NYSE:BA), having delivered 130 commercial airplanes in the first quarter of 2025, with the 737 model accounting for 105 of those deliveries. Its defense, space, and security segment also delivered 26 new units, including 15 Apache helicopters and various fighter jet models. The recent firm order by BOC Aviation 50 737 MAX jets exemplifies this, and it expands the lessor’s 737 MAX portfolio to 215 aircraft. Industry experts project single-aisle jets like the 737 to account for 75% of global deliveries over the next 20 years, positioning Boeing to benefit from airlines’ fleet growth and replacement of less-efficient older jets.

Despite these positive developments, Boeing (NYSE:BA) faces significant headwinds as the ongoing U.S.-China trade tensions have escalated dramatically. On April 15, Bloomberg News reported that China has ordered its airlines to suspend all Boeing deliveries in response to the U.S. imposing 145% tariffs on Chinese goods. Nonetheless, the company’s core business remains solid, with a substantial order backlog and strong demand from markets outside China. On April 16, Jason Sum of DBS reaffirmed his Buy rating on The Boeing Company (NYSE:BA) and set a price target of $240.00.